Press Release

Arthroscopy Devices Market to Grow with a CAGR of 5.56% through 2028

The increasing prevalence of musculoskeletal disorders, a surge in sports-related injuries, and the appeal of minimally invasive techniques are expected to drive the Global Arthroscopy Devices Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Arthroscopy Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Arthroscopy Devices Market stood at USD 6.01 billion in 2022 and is anticipated to grow with a CAGR of 5.56% in the forecast period, 2024-2028. This can be attributed to advancements in technology. Continuous advancements in arthroscopic technology have been a game-changer in the field. High-definition cameras, 3D imaging systems, and precision instruments have improved the accuracy of arthroscopic procedures, enhancing surgical outcomes and patient satisfaction. Surgeons now have access to better tools and equipment, making arthroscopy an attractive option for many joint surgeries.

Additionally, sustainability is becoming a consideration in the medical device industry, including arthroscopy. Manufacturers are focusing on reducing the environmental footprint of their products, from production to disposal. Sustainable practices are also extending to packaging and materials used in devices.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Arthroscopy Devices Market.”

 

The COVID-19 pandemic presented an unprecedented public health crisis, significantly impacting the market under consideration. To prioritize essential healthcare resources, directives were issued in mid-March 2020, instructing surgeons to perform only critical surgical procedures. For example, in April 2020, the Journal of Arthroplasty reported that around 30,000 primary and 3,000 revision knee replacement surgeries were being canceled every week during the early part of 2020. These figures underscore the profound effect of COVID-19 on surgeries related to joint disorders. However, dedicated efforts were made by various healthcare authorities, hospitals, and surgeons to restore arthroplasty procedures to pre-pandemic levels. During the pandemic, Enhanced Recovery after Surgery (ERAS) programs were introduced to reduce hospital stays, morbidity, and surgical complications. Moreover, with the return to regular surgical volumes post-COVID-19, a significant influx of patients occurred due to postponed and canceled surgeries. Thus, changes in surgical protocols have played a role in restoring surgical volumes after the pandemic.

Several factors are driving market growth, including the increasing incidence of sports injuries, a rising geriatric population, and advancements in arthroscopic implant technology. Common sports injuries include fractures, strains, sprains, and dislocations, often treated with rest, ice, compression, and elevation (RICE). However, in cases of severe injuries, arthroscopy may be recommended for diagnosis and treatment. These injuries can affect various body parts and may involve cartilage tears, ligament injuries, joint lining inflammation, or the removal of loose bone or cartilage fragments lodged in a joint. Arthroscopic surgery is valuable for diagnosing and treating these conditions.

In September 2020, the United States Centers for Disease Control (CDC) reported an increase in organized sports participation. Approximately 30 million children and adolescents participate in youth sports annually, with high school athletes accounting for around 2 million injuries, 0.5 million doctor visits, and 30,000 hospitalizations each year. Moreover, over 3.5 million children under 14 receive medical treatment for sports injuries annually, with children aged 5-14 accounting for nearly 40% of all sports-related hospital-treated injuries in the United States in 2020. Sports and recreational activities also contributed to 25% of all traumatic brain injuries among children in the same year. These statistics point to a growing number of injuries necessitating arthroscopic procedures, which is expected to positively impact the market.

However, the average cost of outpatient arthroscopic surgery for complex tears can be significant, ranging from approximately USD 7,400 to 9,000 or more. This cost varies based on factors such as patient age, injury severity, location, associated injuries, and the healthcare facility where the procedure is performed. According to the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization database, outpatient arthroscopic surgery typically costs around USD 8,970. Insured patients typically face out-of-pocket expenses consisting of specialist co-pays, often exceeding USD 100 for hospital co-pays, and coinsurance ranging from 10% to 50% for the procedure, potentially reaching annual out-of-pocket maximums. As of April 2020, the Kaiser Family Foundation reported an average hospital co-pay of USD 132 for outpatient surgery and USD 232 for inpatient surgery, with an average coinsurance rate of 17-18%. These high costs can discourage individuals from opting for arthroscopic procedures, presenting a potential market restraint.

The Global Arthroscopy Devices Market is segmented into application, product, end-user, regional distribution, and company.

Based on its end-user, hospitals and clinics are poised to dominate the Global Arthroscopy Devices Market for several compelling reasons. Firstly, these healthcare institutions serve as the primary hubs for diagnosing and treating a wide range of musculoskeletal disorders and joint-related conditions, which are the core areas of arthroscopic procedures. The well-established infrastructure, access to specialized orthopedic surgeons, and state-of-the-art surgical facilities within hospitals and clinics make them ideal settings for performing arthroscopy surgeries. Moreover, these institutions often have the financial resources to invest in advanced arthroscopy equipment, ensuring that they can offer cutting-edge diagnostic and treatment options to their patients. Additionally, the trust and credibility associated with hospitals and clinics play a crucial role in patient decision-making, further cementing their dominance in the arthroscopy devices market.

Based on region, North America is poised to take the lead in the Arthroscopy Devices Market. Over the last two decades, there has been a significant upswing in the volume of arthroscopic procedures conducted in the region, with knee and hip arthroscopy experiencing the most substantial growth. According to data gleaned from the Humana Claims database, the number of hip arthroscopies has surged nearly seven-fold from 2009 to 2021, with the highest incidence occurring among individuals aged 35-44. The region continues to witness a rise in hip arthroscopies, accompanied by an escalation in both the complexity and diversity of these procedures. This diversity reflects the advancements in arthroscopy products and the robust research ecosystem dedicated to arthroscopic applications.

The surge in arthroscopy procedures in North America is primarily attributed to the increasing prevalence of chronic diseases and orthopedic conditions, particularly among the region's aging population. For instance, a February 2021 article by the Centers for Disease Control and Prevention revealed that musculoskeletal diseases afflict more than half of all individuals in the United States aged 18 and above, with the majority of cases related to trauma, back pain, and arthritis. These conditions necessitate frequent healthcare visits, contributing to the escalating healthcare burden. With the aging demographic in the United States, musculoskeletal diseases are imposing a growing healthcare burden each year, further fueling the demand for arthroscopy devices and driving market growth.

 

Major companies operating in Global Arthroscopy Devices Market are:

  • Arthrex Inc
  • CONMED Corp
  • Johnson & Johnson
  • Karl Storz SE & Co KG
  • Medtronic PLC
  • Richard Wolf GmbH
  • Smith & Nephew PLC
  • Stryker Corp

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The Global Arthroscopy Devices Market is undergoing a transformation driven by innovation, patient-centric care, and the adoption of advanced technologies. The novel advancements represent the future direction of arthroscopy, with a focus on precision, efficiency, and improved patient experiences. As the market continues to evolve, it is crucial for manufacturers, healthcare providers, and regulators to adapt to these trends to ensure that arthroscopy remains at the forefront of orthopedic medicine,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Arthroscopy Devices Market By Application (Knee Arthroscopy, Hip Arthroscopy, Spine Arthroscopy, Shoulder and Elbow Arthroscopy, Others), By Product (Arthroscope, Arthroscopic Implant, Fluid Management System, Radiofrequency (RF) System, Visualization System, Others), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Arthroscopy Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Arthroscopy Devices Market.



Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email:
 [email protected]
Website: 
https://www.techsciresearch.com

Relevant News